Document Detail

Pharmacokinetics of ivermectin after maternal or fetal intravenous administration in sheep.
MedLine Citation:
PMID:  19000259     Owner:  NLM     Status:  MEDLINE    
In pregnant sheep at 120-130 days of gestational age, a study was undertaken in order to characterize the pharmacokinetics and transplacental exchange of Ivermectin after maternal or fetal intravenous administration. Eight pregnant Suffolk Down sheep of 73.2 +/- 3.7 kg body weight (bw) were surgically prepared in order to insert polyvinyl catheters in the fetal femoral artery and vein and amniotic sac. Following 48 h of recovery, the ewes were randomly assigned to two experimental groups. In group 1, (maternal injection) five ewes were treated with an intravenous bolus of 0.2 mg ivermectin/kg bw. In group 2, (fetal injection) three ewes were injected with an intravenous bolus of 1 mg of ivermectin to the fetus through a fetal femoral vein catheter. Maternal and fetal blood and amniotic fluid samples were taken before and after ivermectin administration for a period of 144 h post-treatment. Samples were analyzed by liquid chromatography (HPLC). A computerized non-compartmental pharmacokinetic analysis was performed and the results were compared by means of the Student t-test. The main pharmacokinetic changes observed in the maternal compartment were increases in the volume of distribution and in the half-life of elimination (t((1/2)beta)). A limited maternal-fetal transfer of ivermectin was evidenced by a low fetal Cmax (1.72 +/- 0.6 ng/mL) and AUC (89.1 +/- 11.4 ng.h/mL). While the fetal administration of ivermectin resulted in higher values of clearance (554.1 +/- 177.9 mL/kg) and lower values of t((1/2)beta) (8.0 +/- 1.4 h) and mean residence time (8.0 +/- 2.9 h) indicating that fetal-placental unit is highly efficient in eliminating the drug as well as limiting the transfer of ivermectin from the maternal to fetal compartment.
R Pérez; C Palma; M J Núñez; J Cox
Related Documents :
24791849 - Prenatal diagnosis of a giant epignathus teratoma in the third trimester of pregnancy u...
18537909 - Seasonal variation of reproductive performance, foetal development and progesterone con...
19501989 - Cotyledonary responses to maternal selenium and dietary restriction may influence alter...
16726069 - Factors associated with neonatal lamb mortality.
7424999 - Maternofetal electrical potential difference in conscious sheep: effect of fetal death ...
8452929 - The fetal circadian pacemaker is not involved in the timing of birth in hamsters.
16814289 - Estradiol production during controlled ovarian hyperstimulation correlates with treatme...
15271459 - Major histocompatibility antigen expression on the bovine placenta: its relationship to...
21158489 - Amniotic fluid concentrations of soluble scavenger receptor for hemoglobin (scd163) in ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of veterinary pharmacology and therapeutics     Volume:  31     ISSN:  1365-2885     ISO Abbreviation:  J. Vet. Pharmacol. Ther.     Publication Date:  2008 Oct 
Date Detail:
Created Date:  2008-11-12     Completed Date:  2009-02-12     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7910920     Medline TA:  J Vet Pharmacol Ther     Country:  England    
Other Details:
Languages:  eng     Pagination:  406-14     Citation Subset:  IM    
Laboratorio de Farmacología, Departamento de Ciencias Clínicas, Facultad de Ciencias Veterinarias, Universidad de Concepción, Chillán, Chile.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antiparasitic Agents / administration & dosage,  blood,  pharmacokinetics*
Area Under Curve
Chromatography, High Pressure Liquid
Fetal Blood / chemistry
Fetus / metabolism*
Injections, Intravenous
Ivermectin / administration & dosage,  blood,  pharmacokinetics*
Maternal-Fetal Exchange
Metabolic Clearance Rate
Pregnancy, Animal / metabolism*
Reg. No./Substance:
0/Antiparasitic Agents; 70288-86-7/Ivermectin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Characterization of the pharmacokinetic disposition of levofloxacin in stallions after intravenous a...
Next Document:  Pharmacokinetics of a controlled-release liposome-encapsulated hydromorphone administered to healthy...